219 related articles for article (PubMed ID: 4851001)
21. Adjuvant chemotherapy and immunotherapy in high risk patients with melanoma.
El-Domeiri AA; Das Gupta TK; Trippon M; Simo C; Sabet TY; Crispen R
Surg Gynecol Obstet; 1978 Feb; 146(2):230-2. PubMed ID: 622668
[TBL] [Abstract][Full Text] [Related]
22. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma.
Frei E; Luce JK; Talley RW; Vaitkevicius VK; Wilson HE
Cancer Chemother Rep; 1972 Oct; 56(5):667-70. PubMed ID: 4569060
[No Abstract] [Full Text] [Related]
23. Combination chemotherapy for disseminated malignant melanoma.
Costanzi JJ; Vaitkevicius VK; Quagliana JM; Hoogstraten B; Coltman CA; Delaney FC
Cancer; 1975 Feb; 35(2):342-6. PubMed ID: 1111912
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy of malignant melanoma.
Luce JK
Cancer; 1972 Dec; 30(6):1604-15. PubMed ID: 4565819
[No Abstract] [Full Text] [Related]
25. 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of advanced acute lymphocytic leukemia in children.
Finklestein JZ; Albo V; Ertel I; Karon M; Hammond D
Cancer Chemother Rep; 1972 Aug; 56(4):523-6. PubMed ID: 4507686
[No Abstract] [Full Text] [Related]
26. DTIC (NSC-45388) in malignant melanoma: a perspective.
Comis RL
Cancer Treat Rep; 1976 Feb; 60(2):165-76. PubMed ID: 769969
[No Abstract] [Full Text] [Related]
27. 5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man.
van Eden EB; Falkson G; van Dyk JJ; van der Merwe AM; Falkson HC
Cancer Chemother Rep; 1972 Feb; 56(1):107-47. PubMed ID: 5030803
[No Abstract] [Full Text] [Related]
28. Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanoma.
McKelvey EM; Luce JK; Talley RW; Hersh EM; Hewlett JS; Moon TE
Cancer; 1977 Jan; 39(1):1-4. PubMed ID: 832224
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma.
Ahmann DL; Hahn RG; Bisel HF
Cancer; 1974 Mar; 33(3):615-8. PubMed ID: 4131357
[No Abstract] [Full Text] [Related]
30. [Treatment of metastasising melanoma with a combination of cytostatic agents (author's transl)].
Kleeberg UR; Schreml W
Dtsch Med Wochenschr; 1976 Jun; 101(23):890-4. PubMed ID: 1269431
[TBL] [Abstract][Full Text] [Related]
31. Combination cytotoxic chemotherapy for metastatic cutaneous malignant melanoma with DTIC, BCNU, and vincristine.
Carmo-Pereira J; Oliveira Costa F; Pimentel P
Cancer Treat Rep; 1976 Sep; 60(9):1381-3. PubMed ID: 1016972
[No Abstract] [Full Text] [Related]
32. Prognostic correlations and response to treatment in advanced metastatic malignant melanoma.
Einhorn LH; Burgess MA; Vallejos C; Bodey GP; Gutterman J; Mavligit G; Hersh EM; Luce JK; Frei E; Freireich EJ; Gottlieb JA
Cancer Res; 1974 Aug; 34(8):1995-2004. PubMed ID: 4842252
[No Abstract] [Full Text] [Related]
33. Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma.
Mitchell MS; Mokyr MB; Davis JM
J Clin Invest; 1977 Jun; 59(6):1017-26. PubMed ID: 863999
[TBL] [Abstract][Full Text] [Related]
34. Effective treatment of Kaposi's sarcoma with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
Vogel CL; Primack A; Owor R; Kyalwazi SK
Cancer Chemother Rep; 1973 Feb; 57(1):65-71. PubMed ID: 4704105
[No Abstract] [Full Text] [Related]
35. Procarbazine, vinblastine, and actinomycin D in stage III and IV melanoma with or without methanol-extracted residue of Bacillus Calmette-Guérin.
Kostinas JE; Leone LA; Cuttner J; Vinciguerra V; Green M; De Bellis R; Pajak TF
Cancer Treat Rep; 1979 Feb; 63(2):197-200. PubMed ID: 376132
[TBL] [Abstract][Full Text] [Related]
36. The chemotherapy of malignant melanoma in Nebraska.
Foley JF; Lemon HM; Kessinger A
Nebr Med J; 1973 Jun; 58(6):188-96. PubMed ID: 4708217
[No Abstract] [Full Text] [Related]
37. Combination chemotherapy of malignant melanoma with imidazole carboxamide, BCNU and vincristine.
Cohen SM; Greenspan EM; Ratner LH; Weiner MJ
Cancer; 1977 Jan; 39(1):41-4. PubMed ID: 832250
[TBL] [Abstract][Full Text] [Related]
38. Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
Gams RA; Carpenter JT
Cancer Chemother Rep; 1974; 58(5 Pt 1):753-4. PubMed ID: 4214608
[No Abstract] [Full Text] [Related]
39. Value of adjuvant therapy with bacille Calmette Guerin (BCG) or dimethl triazeno imidazole carboximide (DTIC) in the control of minimal residual disease in stage II melanoma.
Peter HH; Deutschmann KE; Deinhardt J; Deicher H
Recent Results Cancer Res; 1978; 68():367-74. PubMed ID: 752872
[No Abstract] [Full Text] [Related]
40. Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma.
Nathanson L; Wolter J; Horton J; Colsky J; Shnider BI; Schilling A
Clin Pharmacol Ther; 1971; 12(6):955-62. PubMed ID: 5134998
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
